Clinical trial
Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult…
NCT00254956 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00254956 |
|---|---|
| Title | Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma |
| Official title | A Multi-Center, Multinational, Randomized, Double-Blind, Parallel Group Study of the Effects of Ciclesonide Hfa-Mdi 640 μg/Day and Beclomethasone Hfa-Mdi 640 μg/Day on Lens Opacification in Adult Subjects With Moderate to Severe Persistent Asthma |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Takeda Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Respiratory Tract Diseases, Respiratory Hypersensitivity, Asthma |
| Intervention type | Drug |
| Interventions | ciclesonide (XRP1526) |
| Enrollment | 1,568 |
| Start date | Jan 1, 2004 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Nov 17, 2005 |
| Last update posted | Apr 8, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: